Acute Myeloid Leukemia in Remission
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia in Remission.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-10-30Clinical Trial Update: Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion [NA]
Clinical trial update from Baylor College of Medicine reports results for haploidentical hematopoietic cell transplantation using TCR alpha/…
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies [Phase 2]
This Phase 2 trial investigates reduced-intensity chemotherapy and radiation therapy before donor stem cell transplantation for various hema…
-
CLINICAL_TRIALS trial_result · 2024-10-24Clinical Trial Update: Nivolumab in AML in Remission at High Risk for Relapse [Phase 2]
Phase 2 trial evaluating nivolumab for acute myeloid leukemia in remission at high risk for relapse has completed and results have been post…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor natural killer cells and donor stem cell transplant in high-risk myeloid malignancies; completed w…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and Pevonedistat [Phase 2]
Phase 2 clinical trial evaluating azacitidine or ATA in combination with pevonedistat for MDS/AML patients at impending hematological relaps…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies [EARLY_Phase 1]
Early-phase trial investigating irradiated donor cells after stem cell transplant to control cancer in patients with hematologic malignancie…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation in Treating Patients With Hematological Cancer Who Are Undergoing Umbilical Cord Blood Transplant [Phase 2]
Phase 2 clinical trial evaluating treosulfan, fludarabine phosphate, and total-body irradiation as conditioning for umbilical cord blood tra…
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome [Phase 1]
Phase 1 trial of a conditioning regimen including an iodine-131 labeled monoclonal antibody with fludarabine, cyclophosphamide, total-body i…
-
CLINICAL_TRIALS trial_result · 2022-08-19Clinical Trial Update: AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission [Phase 2, Phase 3]
Clinical trial update for AZA plus venetoclax as maintenance therapy in younger adults with AML in first remission (Phase 2/Phase 3).
-
CLINICAL_TRIALS trial_result · 2022-03-24Clinical Trial Update: Study of Azacytidine Combined With Lenalidomide As Maintenance Therapy Based on MRD Monitoring in AML [Phase 3]
Phase 3 trial evaluating azacytidine combined with lenalidomide as maintenance therapy guided by MRD monitoring in acute myeloid leukemia in…
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Evaluation of a Donor Testing Kit for the Prediction of AGVHD in Patient Receiving a Peripheral Blood Stem Cell Allograft [Phase 2, Phase 3]
Phase 2/Phase 3 evaluation of a donor testing kit to predict acute graft-versus-host disease in patients receiving peripheral blood stem cel…
-
CLINICAL_TRIALS trial_result · 2021-07-06Clinical Trial Update: Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes [Phase 2]
Phase 2 trial evaluating donor umbilical cord blood transplant with or without ex-vivo expanded cord blood progenitor cells in patients with…
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients. [Phase 2]
Investigator-initiated Phase II trial of DSP-7888 cancer vaccine in patients with Acute Myeloid Leukemia in remission.
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant [Phase 1, Phase 2]
Clinical trial investigating lenalidomide in older AML patients post-stem cell transplant; study terminated with results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2019-03-05Clinical Trial Update: Infusion of Off-the-Shelf Expanded Cord Blood Cells to Augment Cord Blood Transplant in Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial updating the use of off-the-shelf expanded cord blood cells to augment cord blood transplant in patients with various…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant, Mycophenolate Mofetil, and Cyclosporine in Treating Patients With Fanconi Anemia [Phase 2]
Phase 2 trial evaluating a conditioning regimen with fludarabine, cyclophosphamide, and total-body irradiation followed by donor bone marrow…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease [Phase 2]
Phase 2 study of the combination of clofarabine and cytarabine in adults with acute myeloid leukemia across various cytogenetic subtypes and…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies [Phase 2]
Phase 2 trial updating the use of deferasirox for iron overload due to transfusions in patients with hematologic malignancies; study status …